Slatopolsky E - Search Results

1

Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients.

Coyne DW, Grieff M, Ahya SN, Giles K, Norwood K, Slatopolsky E. Coyne DW, et al. Among authors: slatopolsky e. Am J Kidney Dis. 2002 Dec;40(6):1283-8. doi: 10.1053/ajkd.2002.36899. Am J Kidney Dis. 2002. PMID: 12460048

2

Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.

Ritter C, Miller B, Coyne DW, Gupta D, Zheng S, Brown AJ, Slatopolsky E. Ritter C, et al. Among authors: slatopolsky e. Kidney Int. 2017 Nov;92(5):1217-1222. doi: 10.1016/j.kint.2017.05.003. Epub 2017 Jul 24. Kidney Int. 2017. PMID: 28750928 Free article.

3

Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.

Slatopolsky E, Cozzolino M, Finch JL. Slatopolsky E, et al. Kidney Int. 2002 Oct;62(4):1277-84. doi: 10.1111/j.1523-1755.2002.kid573.x. Kidney Int. 2002. PMID: 12234297 Free article.

4

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.

Slatopolsky EA, Burke SK, Dillon MA. Slatopolsky EA, et al. Kidney Int. 1999 Jan;55(1):299-307. doi: 10.1046/j.1523-1755.1999.00240.x. Kidney Int. 1999. PMID: 9893140 Free article. Clinical Trial.

5

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.

Slatopolsky E, Cozzolino M, Lu Y, Finch J, Dusso A, Staniforth M, Wein Y, Webster J. Slatopolsky E, et al. Kidney Int. 2003 Jun;63(6):2020-7. doi: 10.1046/j.1523-1755.2003.00029.x. Kidney Int. 2003. PMID: 12753289 Free article.

6

Hyperplasia of the parathyroid gland without secondary hyperparathyroidism.

Takahashi F, Denda M, Finch JL, Brown AJ, Slatopolsky E. Takahashi F, et al. Among authors: slatopolsky e. Kidney Int. 2002 Apr;61(4):1332-8. doi: 10.1046/j.1523-1755.2002.00265.x. Kidney Int. 2002. PMID: 11918740 Free article.

7

New vitamin D analogs.

Slatopolsky E, Finch J, Brown A. Slatopolsky E, et al. Kidney Int Suppl. 2003 Jun;(85):S83-7. doi: 10.1046/j.1523-1755.63.s85.20.x. Kidney Int Suppl. 2003. PMID: 12753273 Free article. Review.

8

Calcium, phosphorus and vitamin D disorders in uremia.

Slatopolsky E, Brown A, Dusso A. Slatopolsky E, et al. Contrib Nephrol. 2005;149:261-271. doi: 10.1159/000085687. Contrib Nephrol. 2005. PMID: 15876849 Review.

9

Vitamin D analogs for the treatment of secondary hyperparathyroidism.

Slatopolsky E, Brown AJ. Slatopolsky E, et al. Blood Purif. 2002;20(1):109-12. doi: 10.1159/000046993. Blood Purif. 2002. PMID: 11803167 Review.

10

Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport.

Brown AJ, Finch J, Slatopolsky E. Brown AJ, et al. Among authors: slatopolsky e. J Lab Clin Med. 2002 May;139(5):279-84. doi: 10.1067/mlc.2002.122819. J Lab Clin Med. 2002. PMID: 12032488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters